Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125468981 | 12546898 | 1 | I | 20160611 | 20160630 | 20160711 | 20160711 | EXP | NO-NOMAADVRE-RELISV-2016-22237 | PHHY2016NO090528 | SANDOZ | 85.00 | YR | M | Y | 0.00000 | 20160711 | OT | NO | NO |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125468981 | 12546898 | 1 | PS | DOXYCYCLINE. | DOXYCYCLINE | 1 | Oral | 100 MG, BID | 2000 | MG | Y | 65353 | 100 | MG | BID | ||||
| 125468981 | 12546898 | 2 | SS | ALLOPUR | ALLOPURINOL | 1 | Oral | 300 MG, QD | 2430 | MG | Y | 0 | 300 | MG | QD | ||||
| 125468981 | 12546898 | 3 | C | COLCHICINE. | COLCHICINE | 1 | Oral | Y | 0 | ||||||||||
| 125468981 | 12546898 | 4 | C | ANORO ELLIPTA | UMECLIDINIUM BROMIDEVILANTEROL TRIFENATATE | 1 | Respiratory (inhalation) | 1 DF, QD | 0 | 1 | DF | QD | |||||||
| 125468981 | 12546898 | 5 | C | METOPROLOL SANDOZ//METOPROLOL SUCCINATE | 2 | Oral | 100 MG, QD | 0 | 100 | MG | QD | ||||||||
| 125468981 | 12546898 | 6 | C | FINASTERIDE. | FINASTERIDE | 1 | Oral | 5 MG, QD | 0 | 5 | MG | QD | |||||||
| 125468981 | 12546898 | 7 | C | FOLIC ACID. | FOLIC ACID | 1 | Oral | 1 MG, QD | 0 | 1 | MG | QD | |||||||
| 125468981 | 12546898 | 8 | C | ATOZET | ATORVASTATIN CALCIUMEZETIMIBE | 1 | Oral | 1 DF = 10 MG EZETIMIBE AND 40 MG SIMVASTATIN | 0 | 1 | DF | QD | |||||||
| 125468981 | 12546898 | 9 | C | CYANOCOBALAMIN. | CYANOCOBALAMIN | 1 | Intramuscular | 1 DF, QMO | 0 | 1 | DF | /month | |||||||
| 125468981 | 12546898 | 10 | C | FURIX | FUROSEMIDE | 1 | Oral | 60 MG, QD 40+20 MG | 0 | 60 | MG | QD | |||||||
| 125468981 | 12546898 | 11 | C | PANODIL | ACETAMINOPHEN | 1 | Oral | 1 G, TID | 0 | 1 | G | TID | |||||||
| 125468981 | 12546898 | 12 | C | ESOMEPRAZOLE | ESOMEPRAZOLE | 1 | Oral | 20 MG, QD | 0 | 20 | MG | QD | |||||||
| 125468981 | 12546898 | 13 | C | FERROMAX | 2 | Oral | 65 MG, BID | 0 | 65 | MG | BID | ||||||||
| 125468981 | 12546898 | 14 | C | LANOXIN | DIGOXIN | 1 | Oral | 0.125 MG, QW4 | 0 | .125 | MG | ||||||||
| 125468981 | 12546898 | 15 | C | XARELTO | RIVAROXABAN | 1 | Oral | 15 MG, QD | 0 | 15 | MG | QD | |||||||
| 125468981 | 12546898 | 16 | C | MIRTAZAPINE. | MIRTAZAPINE | 1 | Unknown | 30 MG, QD | 0 | 30 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125468981 | 12546898 | 1 | Skin infection |
| 125468981 | 12546898 | 2 | Gout |
| 125468981 | 12546898 | 3 | Gout |
| 125468981 | 12546898 | 4 | Product used for unknown indication |
| 125468981 | 12546898 | 5 | Product used for unknown indication |
| 125468981 | 12546898 | 6 | Prostatic disorder |
| 125468981 | 12546898 | 7 | Product used for unknown indication |
| 125468981 | 12546898 | 8 | Hypercholesterolaemia |
| 125468981 | 12546898 | 9 | Product used for unknown indication |
| 125468981 | 12546898 | 10 | Chronic kidney disease |
| 125468981 | 12546898 | 11 | Product used for unknown indication |
| 125468981 | 12546898 | 12 | Product used for unknown indication |
| 125468981 | 12546898 | 13 | Product used for unknown indication |
| 125468981 | 12546898 | 14 | Atrial fibrillation |
| 125468981 | 12546898 | 15 | Atrial fibrillation |
| 125468981 | 12546898 | 16 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125468981 | 12546898 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125468981 | 12546898 | General physical health deterioration | |
| 125468981 | 12546898 | Pyrexia | |
| 125468981 | 12546898 | Rash generalised |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125468981 | 12546898 | 1 | 20160522 | 20160601 | 0 | |
| 125468981 | 12546898 | 2 | 20160603 | 20160612 | 0 | |
| 125468981 | 12546898 | 3 | 20160530 | 0 |